These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14872417)

  • 1. Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
    Goodnough LT
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):25-9. PubMed ID: 14872417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
    Poon MC
    Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To general haemostasis--the evidence-based route.
    Erhardtsen E
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion medicine service policies for recombinant factor VIIa administration.
    Goodnough LT; Lublin DM; Zhang L; Despotis G; Eby C
    Transfusion; 2004 Sep; 44(9):1325-31. PubMed ID: 15318856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
    Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B
    Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
    Gerotziafas GT; Zervas K; Arzoglou P; Karavaggeli E; Parashou S; Van Dreden P; Christakis J; Samama MM
    Br J Haematol; 2002 Jun; 117(3):705-8. PubMed ID: 12028045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA; Fischer TH; Wolberg AS
    Br J Haematol; 2007 Jul; 138(1):82-93. PubMed ID: 17555451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
    Kessler C
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A; Hoffman M; Ehrenforth S
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.
    Baxter MS; Schroeder WS; Cheng Y; Bernstein ZP
    Ann Pharmacother; 2006 Nov; 40(11):2053-8. PubMed ID: 17062831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
    Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
    J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.
    Poon MC
    Transfus Med Rev; 2007 Jul; 21(3):223-36. PubMed ID: 17572261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U
    Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.